David Tsao Sells 20,000 Shares of Billiontoone (NASDAQ:BLLN) Stock

Billiontoone, Inc. (NASDAQ:BLLN) CTO David Tsao sold 20,000 shares of Billiontoone stock in a transaction on Monday, June 15th. The shares were sold at an average price of $102.27, for a total value of $2,045,400.00. Following the transaction, the chief technology officer owned 1,000 shares in the company, valued at approximately $102,270. This trade represents a 95.24% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Billiontoone Price Performance

NASDAQ:BLLN traded down $1.32 during mid-day trading on Wednesday, reaching $99.38. 963,691 shares of the stock were exchanged, compared to its average volume of 453,406. The business has a fifty day moving average price of $88.95 and a 200 day moving average price of $87.60. The firm has a market capitalization of $4.57 billion and a PE ratio of 180.69. Billiontoone, Inc. has a 1-year low of $61.96 and a 1-year high of $138.70. The company has a current ratio of 10.92, a quick ratio of 10.58 and a debt-to-equity ratio of 0.18.

Billiontoone (NASDAQ:BLLN) last released its earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.01 by $0.33. The firm had revenue of $108.39 million for the quarter, compared to analyst estimates of $95.81 million. Billiontoone’s revenue was up 83.8% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.39) earnings per share. Research analysts expect that Billiontoone, Inc. will post 0.93 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Perceptive Advisors LLC grew its position in Billiontoone by 26.1% during the 1st quarter. Perceptive Advisors LLC now owns 91,812 shares of the company’s stock worth $7,248,000 after purchasing an additional 19,000 shares in the last quarter. Bank of America Corp DE grew its holdings in shares of Billiontoone by 8,603.4% during the first quarter. Bank of America Corp DE now owns 12,707 shares of the company’s stock valued at $1,003,000 after buying an additional 12,561 shares in the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of Billiontoone by 151.8% during the first quarter. The Manufacturers Life Insurance Company now owns 30,506 shares of the company’s stock valued at $2,408,000 after buying an additional 18,389 shares in the last quarter. Renaissance Technologies LLC purchased a new position in Billiontoone during the 1st quarter valued at about $4,046,000. Finally, Public Employees Retirement System of Ohio purchased a new position in Billiontoone during the 1st quarter valued at about $1,539,000.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. BTIG Research decreased their price target on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Wall Street Zen upgraded shares of Billiontoone from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. JPMorgan Chase & Co. lifted their target price on Billiontoone from $120.00 to $125.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Guggenheim lifted their target price on Billiontoone from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, May 13th. Finally, Wells Fargo & Company decreased their target price on Billiontoone from $110.00 to $90.00 and set an “equal weight” rating on the stock in a report on Thursday, March 5th. Six equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $125.29.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.